Should ACA plans cover weight loss drugs?
Drug makers are doing everything to tap the bottomless well of demand for new obesity drugs — and now, they might get some government help.
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.
Should ACA plans cover weight loss drugs?
Drug makers are doing everything to tap the bottomless well of demand for new obesity drugs — and now, they might get some government help. CMS is considering a technical change that would require insurers to cover obesity drugs in a market of more than 20 million Americans, John Wilkerson writes.
What's Your Reaction?
